MorphoSys ADR earnings beat, Revenue misses in Q2

  • Investing.com
MorphoSys ADR earnings beat, Revenue misses in Q2

Investing.com - MorphoSys ADR reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.

MorphoSys ADR announced earnings per share of $-0.5707 on revenue of $41.04M. Analysts polled by Investing.com anticipated EPS of $-0.5949 on revenue of $41.23M.

MorphoSys ADR shares are up 11% from the beginning of the year and are trading at $14.12 , down-from-52-week-high.They are under-performing the STOXX 600 which is up 16.26% year to date.

MorphoSys ADR follows other major Healthcare sector earnings this month

MorphoSys ADR's report follows an earnings beat by J&J on Wednesday, July 21, 2021, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.

UnitedHealth had beat expectations on Thursday, July 15, 2021 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles